Cargando…

Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes

BOADICEA is a comprehensive risk prediction model for breast and/or ovarian cancer (BC/OC) and for carrying pathogenic variants (PVs) in cancer susceptibility genes. In addition to BRCA1 and BRCA2, BOADICEA version 6 includes PALB2, CHEK2, ATM, BARD1, RAD51C and RAD51D. To validate its predictions f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Møller, Nanna Bæk, Boonen, Desirée Sofie, Feldner, Elisabeth Simone, Hao, Qin, Larsen, Martin, Lænkholm, Anne-Vibeke, Borg, Åke, Kvist, Anders, Törngren, Therese, Jensen, Uffe Birk, Boonen, Susanne Eriksen, Thomassen, Mads, Terkelsen, Thorkild
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220031/ https://www.ncbi.nlm.nih.gov/pubmed/37237042 http://dx.doi.org/10.1038/s41598-023-35755-8

Ejemplares similares

Author Correction: Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes
por: Møller, Nanna Bæk, et al.
Publicado: (2023)

Germline pathogenic variants associated with ovarian cancer: A historical overview
por: Johansen, Emma Lund, et al.
Publicado: (2022)

The BOADICEA model of genetic susceptibility to breast and ovarian cancer
por: Antoniou, A C, et al.
Publicado: (2004)

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
por: Antoniou, A C, et al.
Publicado: (2008)

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
por: Antoniou, A C, et al.
Publicado: (2008)

Remarks on the BOADICEA model of genetic susceptibility to breast and ovarian cancer
por: van Asperen, C J, et al.
Publicado: (2005)

Evaluation of Nine Somatic Variant Callers for Detection of Somatic Mutations in Exome and Targeted Deep Sequencing Data
por: Krøigård, Anne Bruun, et al.
Publicado: (2016)

Clinical software development for the Web: lessons learned from the BOADICEA project
por: Cunningham, Alex P, et al.
Publicado: (2012)

BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer
por: Nilsson, Martin P., et al.
Publicado: (2017)

Reply: Remarks on the BOADICEA model of genetic susceptibility to breast and ovarian Cancer Research UK
por: Antoniou, A C, et al.
Publicado: (2005)

Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer
por: Ståhlbom, Anne Kinhult, et al.
Publicado: (2011)

Use of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countries
por: Brédart, Anne, et al.
Publicado: (2017)

Streamlining Decision Making in Contralateral Risk-Reducing Mastectomy: Impact of PREDICT and BOADICEA Computations
por: de Silva, Tania Samantha, et al.
Publicado: (2018)

Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model
por: Mavaddat, Nasim, et al.
Publicado: (2023)

Deleterious mis‐splicing of STK11 caused by a novel single‐nucleotide substitution in the 3′ polypyrimidine tract of intron five
por: Terkelsen, Thorkild, et al.
Publicado: (2020)

Machine learning techniques for personalized breast cancer risk prediction: comparison with the BCRAT and BOADICEA models
por: Ming, Chang, et al.
Publicado: (2019)

Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre
por: MacInnis, R J, et al.
Publicado: (2013)

BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface
por: Lee, A J, et al.
Publicado: (2014)

Incorporating Truncating Variants in PALB2, CHEK2 and ATM into the BOADICEA Breast Cancer Risk Model
por: Lee, Andrew J., et al.
Publicado: (2016)

BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors
por: Lee, Andrew, et al.
Publicado: (2019)

Machine learning-based lifetime breast cancer risk reclassification compared with the BOADICEA model: impact on screening recommendations
por: Ming, Chang, et al.
Publicado: (2020)

Correction: BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors
por: Lee, Andrew, et al.
Publicado: (2019)

Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study
por: Yang, Xin, et al.
Publicado: (2022)

Towards a better understanding of the role of psychological variables in arthritis outcome research
por: Boonen, Annelies
Publicado: (2010)

Clonal expansion and linear genome evolution through breast cancer progression from pre-invasive stages to asynchronous metastasis
por: Krøigård, Anne Bruun, et al.
Publicado: (2015)

Identification of metastasis driver genes by massive parallel sequencing of successive steps of breast cancer progression
por: Krøigård, Anne Bruun, et al.
Publicado: (2018)

Expanding the genotype–phenotype spectrum in hereditary colorectal cancer by gene panel testing
por: Rohlin, Anna, et al.
Publicado: (2016)

Precision Oncology of High-Grade Ovarian Cancer Defined through Targeted Sequencing
por: Wessman, Sandra, et al.
Publicado: (2021)

Genetic clinicians' confidence in BOADICEA comprehensive breast cancer risk estimates and counselees' psychosocial outcomes: A prospective study
por: Brédart, Anne, et al.
Publicado: (2022)

RNA profiling reveals familial aggregation of molecular subtypes in non-BRCA1/2 breast cancer families
por: Larsen, Martin J, et al.
Publicado: (2014)

Solvency II solvency capital requirement for life insurance companies based on expected shortfall
por: Boonen, Tim J.
Publicado: (2017)

The effect of anti-inflammatory treatment on depressive symptoms in spondyloarthritis: does the type of drug matter?
por: Webers, Casper, et al.
Publicado: (2022)

Genomic Analyses of Breast Cancer Progression Reveal Distinct Routes of Metastasis Emergence
por: Krøigård, Anne Bruun, et al.
Publicado: (2017)

Monocytes/Macrophages Upregulate the Hyaluronidase HYAL1 and Adapt Its Subcellular Trafficking to Promote Extracellular Residency upon Differentiation into Osteoclasts
por: Puissant, Emeline, et al.
Publicado: (2016)

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families
por: Antoniou, Antonis C, et al.
Publicado: (2006)

Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort
por: Lakeman, Inge M. M., et al.
Publicado: (2020)

Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation in Asian breast cancer patients
por: Ang, Boon Hong, et al.
Publicado: (2022)

Assessing the relative efficacy of different agents based on the outcomes from meta-analyses
por: Boonen, S, et al.
Publicado: (2008)

The challenging interplay between rheumatoid arthritis, ageing and comorbidities
por: van Onna, Marloes, et al.
Publicado: (2016)

Rheumatoid factor and anti-CCP do not predict progressive joint damage in patients with early rheumatoid arthritis treated with prednisolone: a randomised study
por: Hafström, Ingiäld, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6sss2hhq28t99huqji6mi6tmgl